Literature DB >> 26855502

Old but Still Relevant: High Resolution Electrophoresis and Immunofixation in Multiple Myeloma.

Aroonima Misra1, Jyoti Mishra1, Jagan Chandramohan1, Atul Sharma2, Vinod Raina2, Rajive Kumar1, Sushant Soni1, Anita Chopra1.   

Abstract

INTRODUCTION: High resolution electrophoresis (HRE) and immunofixation (IFX) of serum and urine are integral to the diagnostic work-up of multiple myeloma. Unusual electrophoresis patterns are common and may be misinterpreted. Though primarily the responsibility of the hematopathologist, clinicians who are responsible for managing myelomas may benefit from knowledge of these. In this review article we intend to discuss the patterns and importance of electrophoresis in present day scenario.
METHODS: Patterns of HRE and IFX seen in our laboratory over the past 15 years were studied.
RESULTS: Monoclonal proteins are seen on HRE as sharply defined bands, sometimes two, lying from γ- to α-globulin regions on a background of normal, increased or decreased polyclonal γ-globulins, showing HRE to be a rapid and dependable method of detecting M-protein in serum or urine. Immunofixation complements HRE and due to its greater sensitivity, is able to pick up small or light chain bands, not apparent on electrophoresis, including biclonal disease even when electrophoresis shows only one M-band. Special features liable to misinterpretation are discussed. Familiarity with the interpretation of the varied patterns seen in health and disease is essential for providing dependable laboratory support in the management of multiple myeloma.

Entities:  

Keywords:  High resolution electrophoresis; Immunofixation; Myeloma

Year:  2015        PMID: 26855502      PMCID: PMC4733669          DOI: 10.1007/s12288-015-0605-3

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  23 in total

1.  Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Authors:  A R Bradwell; H D Carr-Smith; G P Mead; L X Tang; P J Showell; M T Drayson; R Drew
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

Review 2.  IgE myeloma: a case presentation and a review of the literature.

Authors:  K J Kairemo; M Lindberg; M Prytz
Journal:  Scand J Clin Lab Invest       Date:  1999-10       Impact factor: 1.713

3.  Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).

Authors:  Małgorzata Kuliszkiewicz-Janus; Anna Zimny; Violetta Sokolska; Marek Saşiadek; Kazimierz Kuliczkowski
Journal:  Leuk Lymphoma       Date:  2005-07

4.  3. The laboratory investigation of monoclonal gammopathies.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1978-11       Impact factor: 7.616

5.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

6.  Kappa and lambda light chain disease: survival rates and clinical manifestations.

Authors:  C Shustik; D E Bergsagel; W Pruzanski
Journal:  Blood       Date:  1976-07       Impact factor: 22.113

7.  Trimolecular complexes of lambda light chain dimers in serum of a patient with multiple myeloma.

Authors:  Roshini S Abraham; M Cristine Charlesworth; Barbara A L Owen; Linda M Benson; Jerry A Katzmann; Craig B Reeder; Robert A Kyle
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

8.  Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies.

Authors:  Stephen J Harding; Graham P Mead; Arthur R Bradwell; Annie M Berard
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

Review 9.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Authors:  A Dispenzieri; R Kyle; G Merlini; J S Miguel; H Ludwig; R Hajek; A Palumbo; S Jagannath; J Blade; S Lonial; M Dimopoulos; R Comenzo; H Einsele; B Barlogie; K Anderson; M Gertz; J L Harousseau; M Attal; P Tosi; P Sonneveld; M Boccadoro; G Morgan; P Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

Review 10.  Unusual myelomas: a review of IgD and IgE variants.

Authors:  Shivlal Pandey; Robert A Kyle
Journal:  Oncology (Williston Park)       Date:  2013-08       Impact factor: 2.990

View more
  1 in total

1.  Excess Free Light Chains in Serum Immunofixation Electrophoresis: Attributes of a Distinctive Pattern.

Authors:  Bharani Vani; Aggarwal Ritu; Sharma Praveen; Malhotra Pankaj; Ranjana Minz
Journal:  Indian J Hematol Blood Transfus       Date:  2018-01-31       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.